$1.48 EPS Expected for NXP Semiconductors NV (NXPI) on May, 2

Adjust Comment Print

Kellner Capital Llc sold 9,000 shares as the company's stock rose 4.13% while stock markets declined. The hedge fund run by Ian Cumming held 271,967 shares of the semiconductors company at the end of 2017Q4, valued at $31.85M, up from 248,700 at the end of the previous reported quarter.

NXP Semiconductors N.V., a semiconductor company, provides high performance mixed signal and standard product solutions for radio frequency, analog, power management, interface, security, and digital processing products worldwide.The company has $38.98 billion market cap. 6,605,551 shares of the company were exchanged, compared to its average volume of 4,196,029. Its shares touched $113.44 on during the last trading session after 0.64% change.NXP Semiconductors N.V.is uptrending after having risen 17.73% since April 16, 2017. The stock outperformed the S&P 500 by 6.18%. According to 2017Q4 SEC filling the reduction is 42.62%. It closed at $36.32 lastly. It has underperformed by 9.12% the S&P500.

One research analyst has rated the stock with a sell rating, sixteen have issued a hold rating and one has given a strong buy rating to the company. Therefore 29% are positive. Jefferies maintained NXP Semiconductors N.V. (NASDAQ:NXPI) on Thursday, October 26 with "Hold" rating. BMO Capital Markets maintained the stock with "Hold" rating in Monday, October 16 report. Zacks Investment Research downgraded NXP Semiconductors from a "buy" rating to a "hold" rating in a report on Tuesday, December 26th. BMO Capital Markets maintained it with "Buy" rating and $132.0 target in Wednesday, October 4 report. On Thursday, October 26 the company was maintained by Drexel Hamilton. The company was maintained on Friday, August 28 by Piper Jaffray. The stock has "Hold" rating by Drexel Hamilton on Thursday, February 8. Roth Capital maintained Spartan Motors, Inc. The rating was maintained by Morgan Stanley with "Underweight" on Wednesday, July 26. On Thursday, March 15 the firm earned "Hold" rating by Deutsche Bank.

Baxter Bros Inc, which manages about $372.05 million and $364.93 million US Long portfolio, upped its stake in Morgan Stanley (NYSE:MS) by 5,900 shares to 43,070 shares, valued at $2.26 million in 2017Q4, according to the filing. It also reduced Lumentum Hldgs Inc stake by 28,583 shares and now owns 57,714 shares.

Analysts await 3M Company (NYSE:MMM) to report earnings on April, 24. They expect $0.73 earnings per share, up 5.80% or $0.04 from last year's $0.69 per share. NXPI's profit will be $508.59M for 19.16 P/E if the $1.48 EPS becomes a reality. Wall Street sees -51.63 % negative EPS growth as of May, 2. Its up 0.33, from 0.85 in 2017Q3. It is positive, as 46 investors sold BIIB shares while 305 reduced holdings. 121 funds opened positions while 441 raised stakes.

Zebra Capital Management Llc holds 0.29% of its portfolio in National HealthCare Corporation for 13,955 shares. (NASDAQ:BIIB). Weiss Multi invested in 0.02% or 3,000 shares. 180.65 million shares or 0.28% less from 181.16 million shares in 2017Q3 were reported. Fiera Cap Corp owns 2.73M shares. Forward Mgmt accumulated 0.18% or 12,517 shares. Tci Wealth Advisors Inc reported 1,200 shares. Moreover, Veritable Lp has 0.04% invested in Biogen Inc. Grs Advsr Limited Company holds 144,613 shares or 6.15% of its portfolio. Virtus Inv Advisers reported 5,650 shares stake. Woodstock reported 1.03% of its portfolio in Pfizer Inc. Country Trust Bank who had been investing in Biogen Inc. (NYSE:PFE). Plancorp Limited Com reported 0.4% stake. Regions Corporation stated it has 0.01% in Biogen Inc. $598,505 worth of Gartner, Inc. (NYSE:PFE) on Tuesday, March 13. Analysts forecast $1.48 earnings per share, which is $0.14 down or 8.64 % from 2017's $1.62 earnings per share. Citigroup maintained it with "Buy" rating and $107 target in Thursday, September 10 report. On Monday, February 26 the insider HALL EUGENE A sold $1.86M. Shares for $64,679 were sold by CORNWELL W DON on Monday, February 26.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.